In addition, IL-9 was significantly increased in the PBMC of chronic lymphocytic leukemia (CLL) patients compared with levels in normal individuals, and the increased IL-9 was related to the clinical staging, ZAP-70 expression, β2 microglobulin expression and IgVH status of CLL patients. The gene discussed is IL9; the disease is B-cell chronic lymphocytic leukemia.